Stjepanovic MI et al. |
Pulmonary and Vertebral Mycobacterium avium Disease in a HIV-negative 71-year-old Man - A Case Report. |
2016 |
Infez Med |
pmid:28011973
|
Ramzy I et al. |
GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS. |
2016 |
Rev. Inst. Med. Trop. Sao Paulo |
pmid:27982354
|
Muñoz-Egea MC et al. |
Effect of Antibiotics and Antibiofilm Agents in the Ultrastructure and Development of Biofilms Developed by Nonpigmented Rapidly Growing Mycobacteria. |
2016 |
Microb. Drug Resist. |
pmid:26208145
|
Salimi A et al. |
Toxicity of macrolide antibiotics on isolated heart mitochondria: a justification for their cardiotoxic adverse effect. |
2016 |
Xenobiotica |
pmid:26068526
|
Liou JM et al. |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. |
2016 |
Lancet |
pmid:27769562
|
Campillo A et al. |
[10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection]. |
2016 |
Gastroenterol Hepatol |
pmid:27084668
|
Chauffour A et al. |
Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice. |
2016 |
PLoS Negl Trop Dis |
pmid:27755552
|
Abuhammour A et al. |
Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients. |
2016 |
Arab J Gastroenterol |
pmid:27665525
|
Matsumoto H et al. |
Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance. |
2016 |
Dig. Dis. Sci. |
pmid:27659671
|
Kasai C et al. |
Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection. |
2016 |
BMC Gastroenterol |
pmid:27716077
|
Gisbert JP |
Helicobacter pylori-related diseases. |
2016 |
Gastroenterol Hepatol |
pmid:27888863
|
Noda H et al. |
A Novel Potassium-Competitive Acid Blocker Improves the Efficacy of Clarithromycin-containing 7-day Triple Therapy against Helicobacter pylori. |
2016 |
J Gastrointestin Liver Dis |
pmid:27689190
|
Donzelli A |
Helicobacter pylori Eradication? |
2016 |
Gastroenterology |
pmid:27590693
|
Rossi A et al. |
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations. |
2016 |
Drug Dev Ind Pharm |
pmid:26065531
|
Morimoto K et al. |
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases. |
2016 |
Ann Am Thorac Soc |
pmid:27513168
|
Christianson S et al. |
Time-to-Detection of Inducible Macrolide Resistance in Mycobacterium abscessus Subspecies and Its Association with the Erm(41) Sequevar. |
2016 |
PLoS ONE |
pmid:27490181
|
Harada T et al. |
Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model. |
2016 |
J. Pharmacol. Exp. Ther. |
pmid:27489022
|
Bonfigli AR et al. |
Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients. |
2016 |
Nutr Metab Cardiovasc Dis |
pmid:27480449
|
Orrin E et al. |
Sporotrichoid Mycobacterium chelonae. |
2016 |
Australas. J. Dermatol. |
pmid:27469486
|
Yamamoto K et al. |
Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3. |
2016 |
Pharmacol. Res. |
pmid:27468646
|
Ferro BE et al. |
Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27458221
|
Patton PH et al. |
Anti-tuberculous therapy for maintenance of remission in Crohn's disease. |
2016 |
Cochrane Database Syst Rev |
pmid:27444319
|
Christl I et al. |
Clarithromycin and Tetracycline Binding to Soil Humic Acid in the Absence and Presence of Calcium. |
2016 |
Environ. Sci. Technol. |
pmid:27438991
|
Luo XF et al. |
Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori. |
2016 |
World J. Gastroenterol. |
pmid:27433095
|
Hirasawa K et al. |
Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell Lines. |
2016 |
PLoS ONE |
pmid:27977675
|
Mougari F et al. |
Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. |
2016 |
Expert Rev Anti Infect Ther |
pmid:27690688
|
Steurer J |
[Months of antibiotic therapy in persistent symptoms of Lyme disease without effect]. |
2016 |
Praxis (Bern 1994) |
pmid:27269781
|
Chung JW et al. |
Ten-day empirical sequential or concomitant therapy is more effective than triple therapy for Helicobacter pylori eradication: A multicenter, prospective study. |
2016 |
Dig Liver Dis |
pmid:27257049
|
Mitchell H and Katelaris P |
Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection. |
2016 |
Med. J. Aust. |
pmid:27256648
|
Ullah S et al. |
Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin. |
2016 |
Drug Deliv |
pmid:27247018
|
Kuo CH et al. |
A Rapid and Accurate Method to Evaluate Helicobacter pylori Infection, Clarithromycin Resistance, and CYP2C19 Genotypes Simultaneously From Gastric Juice. |
2016 |
Medicine (Baltimore) |
pmid:27227911
|
Sluch IM et al. |
Mycobacterium chelonae Scleral Abscess After Intravitreal Ranibizumab Injection. |
2016 |
Cornea |
pmid:27227391
|
Laird-Fick HS et al. |
Gastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts. |
2016 |
Postgrad Med J |
pmid:27222587
|
Phiphatpatthamaamphan K et al. |
Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study. |
2016 |
Asian Pac. J. Cancer Prev. |
pmid:27221874
|
Parize P et al. |
Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts. |
2016 |
J Eur Acad Dermatol Venereol |
pmid:25677464
|
Xu J et al. |
Preparation, characterization and pharmacokinetics evaluation of clarithromycin-loaded Eudragit(®) L-100 microspheres. |
2016 |
Eur J Drug Metab Pharmacokinet |
pmid:25652786
|
EmiralioÄŸlu N et al. |
Pulmonary Mycobacterium abscessus Infection in a Patient with Triple A Syndrome. |
2016 |
J. Trop. Pediatr. |
pmid:27080471
|
Graham DY and Dore MP |
Helicobacter pylori therapy: a paradigm shift. |
2016 |
Expert Rev Anti Infect Ther |
pmid:27077447
|
Song ZQ et al. |
Hybrid Therapy Regimen for Helicobacter Pylori Eradication. |
2016 |
Chin. Med. J. |
pmid:27064046
|
Matsumoto H et al. |
Molecular Detection of H. pylori Using Adherent Gastric Mucous to Biopsy Forceps. |
2016 |
Helicobacter |
pmid:27061611
|
Tsaganos T et al. |
Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27044546
|
Buchicchio A et al. |
Biodegradation of carbamazepine and clarithromycin by Trichoderma harzianum and Pleurotus ostreatus investigated by liquid chromatography - high-resolution tandem mass spectrometry (FTICR MS-IRMPD). |
2016 |
Sci. Total Environ. |
pmid:27039063
|
Melia MT and Auwaerter PG |
Time for a Different Approach to Lyme Disease and Long-Term Symptoms. |
2016 |
N. Engl. J. Med. |
pmid:27028918
|
Berende A et al. |
Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease. |
2016 |
N. Engl. J. Med. |
pmid:27028911
|
D'Erme AM et al. |
Successful treatment of rosacea fulminans in a 59-year-old woman with macrolide antibiotics and prednisone. |
2016 |
Int. J. Dermatol. |
pmid:27028670
|
Klesiewicz K et al. |
Anti-Helicobacter pylori activity of some newly synthesized derivatives of xanthone. |
2016 |
J. Antibiot. |
pmid:27025351
|
Kawashima K et al. |
Successful eradication of Helicobacter pylori infection with vonoprazan-based triple therapy after failure of PPI-based triple therapy. |
2016 |
Dig Liver Dis |
pmid:27012448
|
Belz D et al. |
Mycobacterium marinum infection initially diagnosed as metastatic Crohn's disease. |
2016 |
J Eur Acad Dermatol Venereol |
pmid:25510444
|
Meng X et al. |
[Antibiotic resistance of Helicobacter pylori clinical isolates in Hebei Province]. |
2016 |
Zhonghua Yi Xue Za Zhi |
pmid:26879786
|
Bakshi SS |
Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion. |
2016 |
J Laryngol Otol |
pmid:26878377
|
Franceschi F et al. |
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infection. |
2016 |
Eur Rev Med Pharmacol Sci |
pmid:26875899
|
Tepeš B et al. |
Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication. |
2016 |
Eur J Gastroenterol Hepatol |
pmid:26862930
|
Lim SG et al. |
The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use. |
2016 |
Dig Liver Dis |
pmid:26856963
|
Niv Y |
Doxycycline in Eradication Therapy of Helicobacter pylori--a Systematic Review and Meta-Analysis. |
2016 |
Digestion |
pmid:26849820
|
Song Z et al. |
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy. |
2016 |
Dig Liver Dis |
pmid:26847964
|
Vannarath S et al. |
Antibiotic Resistant Pattern of Helicobacter Pylori Infection Based on Molecular Tests in Laos. |
2016 |
Asian Pac. J. Cancer Prev. |
pmid:26838225
|
Miyamoto S et al. |
Analysis of Helicobacter pylori genotypes in clinical gastric wash samples. |
2016 |
Tumour Biol. |
pmid:26825980
|
Bohnert JA et al. |
Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26824939
|
Vermeer LM et al. |
Evaluation of Ketoconazole and Its Alternative Clinical CYP3A4/5 Inhibitors as Inhibitors of Drug Transporters: The In Vitro Effects of Ketoconazole, Ritonavir, Clarithromycin, and Itraconazole on 13 Clinically-Relevant Drug Transporters. |
2016 |
Drug Metab. Dispos. |
pmid:26668209
|
Meng Y et al. |
Multi-functional Liposomes Enhancing Target and Antibacterial Immunity for Antimicrobial and Anti-Biofilm Against Methicillin-Resistant Staphylococcus aureus. |
2016 |
Pharm. Res. |
pmid:26666773
|
Konstantinidis T et al. |
Immunomodulatory Role of Clarithromycin in Acinetobacter baumannii Infection via Formation of Neutrophil Extracellular Traps. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26643338
|
Ferro BE et al. |
Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26643335
|
Wu TS et al. |
Postcesarean section wound infection caused by Mycobacterium massiliense. |
2016 |
J Microbiol Immunol Infect |
pmid:26350122
|
Kamiya K et al. |
Erythema multiforme caused by triple therapy with amoxicillin, clarithromycin and vonoprazan for Helicobacter pylori. |
2016 |
J. Dermatol. |
pmid:26508502
|
Mark TM and Coleman M |
It's Time to Take Clarithromycin Seriously in Multiple Myeloma. |
2016 |
Acta Haematol. |
pmid:26505907
|
Qiu XH et al. |
Clarithromycin Synergistically Enhances Thalidomide Cytotoxicity in Myeloma Cells. |
2016 |
Acta Haematol. |
pmid:26505646
|
Senatore FJ et al. |
Helicobacter pylori treatment: Still a work in progress. |
2016 |
Postgrad Med |
pmid:26490697
|
Shin WG et al. |
Eradication Rates of Helicobacter pylori in Korea Over the Past 10 years and Correlation of the Amount of Antibiotics Use: Nationwide Survey. |
2016 |
Helicobacter |
pmid:26470999
|
Narita M et al. |
Antimicrobial Susceptibility of Microorganisms Isolated from Periapical Periodontitis Lesions. |
2016 |
Bull. Tokyo Dent. Coll. |
pmid:27665691
|
Ghaith D et al. |
Mutations affecting domain V of the 23S rRNA gene in Helicobacter pylori from Cairo, Egypt. |
2016 |
J Chemother |
pmid:26358218
|
Yoon H et al. |
Effects of N-acetylcysteine on First-Line Sequential Therapy for Helicobacter pylori Infection: A Randomized Controlled Pilot Trial. |
2016 |
Gut Liver |
pmid:26347514
|
Liou JM et al. |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of in the community and hospital populations: a randomised trial. |
2016 |
Gut |
pmid:26338825
|
Tsujimae M et al. |
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori. |
2016 |
Digestion |
pmid:28030862
|
Cavkaytar S et al. |
Clarithromycin regresses endometriotic implants in rat endometriosis model. |
2015 |
J Obstet Gynaecol |
pmid:26156575
|
Bai P et al. |
Susceptibility of Helicobacter pylori to antibiotics in Chinese patients. |
2015 |
J Dig Dis |
pmid:26147515
|
Nie W et al. |
Species Identification and Clarithromycin Susceptibility Testing of 278 Clinical Nontuberculosis Mycobacteria Isolates. |
2015 |
Biomed Res Int |
pmid:26146620
|
Reveiz L and Cardona AF |
Antibiotics for acute laryngitis in adults. |
2015 |
Cochrane Database Syst Rev |
pmid:26002823
|
Ahmed S and Atia NN |
Simultaneous determination of triple therapy for Helicobacter pylori in human plasma by reversed phase chromatography with online wavelength switching. |
2015 |
Spectrochim Acta A Mol Biomol Spectrosc |
pmid:25459696
|
Harb AH et al. |
Systematic review and meta-analysis: full- vs. half-dose anti-microbials in clarithromycin-based regimens for Helicobacter pylori eradication. |
2015 |
Aliment. Pharmacol. Ther. |
pmid:26011564
|
Rose SJ et al. |
Mycobacterium avium Possesses Extracellular DNA that Contributes to Biofilm Formation, Structural Integrity, and Tolerance to Antibiotics. |
2015 |
PLoS ONE |
pmid:26010725
|
Zhang S et al. |
Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model. |
2015 |
Cancer Lett. |
pmid:25853150
|
Zhang S and Long C |
Pediatric Pharyngeal IgD-positive Monoclonal Plasmacytoid and Plasma Cell Neoplasm. |
2015 |
J. Pediatr. Hematol. Oncol. |
pmid:25851555
|
Burton AJ et al. |
Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25824218
|
Kazama I et al. |
Macroscopic haemoglobinuria associated with Mycoplasma pneumoniae infection successfully treated by clarithromycin. |
2015 |
Infez Med |
pmid:25819056
|
Kimko H et al. |
Helicobacter pylori treatment in children: defining a dose for rabeprazole as a part of a triple therapy regimen. |
2015 |
J Clin Pharmacol |
pmid:25639255
|
Berry AC et al. |
Not All Helicobacter Are pylori. |
2015 |
Clin. Gastroenterol. Hepatol. |
pmid:25638590
|
Dinca EB et al. |
The dangers of gastritis: a case of clarithromycin-associated brief psychotic episode. |
2015 |
J. Nerv. Ment. Dis. |
pmid:25629665
|
Galvidis I et al. |
Group determination of 14-membered macrolide antibiotics and azithromycin using antibodies against common epitopes. |
2015 |
Anal. Biochem. |
pmid:25256165
|
Kim H et al. |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia. |
2015 |
Ann. Hematol. |
pmid:25501820
|
Phan TN et al. |
High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam. |
2015 |
Int. J. Antimicrob. Agents |
pmid:25499186
|
Adebisi AO et al. |
Formulation and evaluation of floating mucoadhesive alginate beads for targeting Helicobacter pylori. |
2015 |
J. Pharm. Pharmacol. |
pmid:25496042
|
Jesus FP et al. |
In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26459895
|
Higuchi K et al. |
Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study. |
2015 |
Gastric Cancer |
pmid:25098924
|
Basyigit S et al. |
The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study. |
2015 |
Bosn J Basic Med Sci |
pmid:26614852
|
Wu IT et al. |
Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan. |
2015 |
World J. Gastroenterol. |
pmid:26457027
|
Barni S et al. |
Azithromycin is more allergenic than clarithromycin in children with suspected hypersensitivity reaction to macrolides. |
2015 |
J Investig Allergol Clin Immunol |
pmid:25997306
|
Fasciana T et al. |
Resistance to clarithromycin and genotypes in Helicobacter pylori strains isolated in Sicily. |
2015 |
J. Med. Microbiol. |
pmid:26338221
|
Curth HM et al. |
Effects of Helicobacter pylori Eradication in Chronic Spontaneous Urticaria: Results from a Retrospective Cohort Study. |
2015 |
Am J Clin Dermatol |
pmid:26334425
|
Zhu YC et al. |
Rapid prediction of inducible clarithromycin resistance in Mycobacterium abscessus. |
2015 |
Mol. Cell. Probes |
pmid:26334290
|
Georgopoulos SD et al. |
Treatment of Helicobacter Pylori infection: optimization strategies in a high resistance era. |
2015 |
Expert Opin Pharmacother |
pmid:26330278
|